Anti-Ma2-Associated Limbic Encephalitis after Termination of Immune Checkpoint Inhibitor Therapy for Malignant Pleural Mesothelioma

Neurological adverse events of immune checkpoint inhibitor (ICI) therapy mostly develop within 3 months after initiation of ICI treatment. An 82-year-old male with malignant pleural mesothelioma developed anti-Ma2-associated limbic encephalitis at a delay of 18 months after the start of nivolumab th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Rei, Tanabe, Etsuko, Otsuka, Yoshihisa, Yoneda, Yukihiro, Kageyama, Yasufumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Single Case − General Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647130/
https://www.ncbi.nlm.nih.gov/pubmed/34950011
http://dx.doi.org/10.1159/000519763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647130/
https://www.ncbi.nlm.nih.gov/pubmed/34950011
http://dx.doi.org/10.1159/000519763

Ejemplares similares